Summary
The nature of circulating immune complexes (CIC) which appear in patients with type B hepatitis was investigated using a method of Raji cell fluorescent immunoassay. CIC were found in seventeen of thirty-five cases (48.6%) with HBs antigen (HBsAg)-positive liver diseases (4/8 cases with acute hepatitis, 9/18 cases with chronic hepatitis, and 4/9 cases with liver cirrhosis), whereas no CIC were detectable in sera of ten asymptomatic, healthy carriers with HB virus. Among the seventeen cases with CIC-positive liver diseases, HBs antigen-antibody immune complexes (HBsIC) were demonstrated in eleven (65%). A high incidence (54%) of proteinuria was observed in patients with CIC-positive liver diseases compared to those without them (10%). Moreover, 83% of patients with HBsIC were associated with proteinuria. A case of fulminant type B hepatitis showed high titers of both CIC and HBsIC during the acute phase of the disease; in the recovery stage, the titers decreased to within normal ranges.
These results demonstrate that HBsAg is a possible antigen in CIC during type B hepatitis. Determination of serum HBsIC is significant for the clinical evaluation of HB virus-related liver diseases.
Similar content being viewed by others
References
Almeida JD, et al: Immune complexes in hepatitis. Lancet ii: 983, 1969
Stannard LM, et al: Electron microscopic study of the distribution of the Australia antigen in individual sera of 50 serologically positive blood donors and two patients with serum hepatitis. J Clin Pathol 26: 209, 1973
Trepo CG, et al: The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 27: 863, 1974
Digeon M. et al: Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. J Immunol Method 16: 165, 1977
Thomas HC, et al: Immune complexes in acute and chronic liver disease. Clin Exp Immunol 31: 150, 1978
Nydegger UE, et al: Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. J Clin Invest 54: 297, 1974
Daugharth H, et al: Autoimmune implication of immune complexes in clinical variants of hepatitis of hepatitis B. Clin Exp Immunol 37: 213, 1979
Madalinski K, et al: HBsAg immune complexes in the course of infection with hepatitis B virus. Clin Exp Immunol 36: 371, 1979
Theofilopoulos AN, et al: Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med 140: 877, 1974
Kohler PF: Clinical immune complex disease. Manifestation in systemic lupus erythematosus and hepatitis B virus infection. Medicine 52: 419, 1973
Combes B, et al: Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet ii: 234. 1971
Kohler PF, et al: Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med 81: 448, 1974
Brzosko WJ, et al: Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet ii: 477, 1974
Silver MM, et al: Hepatitis B-associated membranous glomerulonephritis in a child. Am J Clin Pathol 72: 1034, 1979
Slusarczyk J, et al: Membranous glomerulopathy associated with hepatitis core antigen immune complexes in children. Am J Pathol 98: 29, 1980
Maggiore Q, et al: HBsAg glomerular deposits in glomerulonephritis: Fact or artifact? Kidney Int 19: 579, 1981
Takekoshi Y, et al: Free “small” and IgG-associated “large” hepatitis B e antigen in the serum and glomerlar capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 300: 814, 1979
Author information
Authors and Affiliations
Additional information
This study was supported in part by Grants 348187 from the Japanese Ministry of Education, Science and Culture.
Rights and permissions
About this article
Cite this article
Sugiura, K., Hasumura, Y. & Takeuchi, J. Significance of circulating HBs antigen-antibody immune complexes in patients with HBs antigen-positive liver disease. Gastroenterol Jpn 17, 241–245 (1982). https://doi.org/10.1007/BF02776003
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02776003